Actinium Announces Closing of Public Offering of Common Stock
October 04, 2016 16:15 ET
|
Actinium Pharmaceuticals
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Pricing of Public Offering of Common Stock
September 29, 2016 08:15 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Proposed Public Offering of Common Stock
September 28, 2016 16:10 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60
September 27, 2016 07:00 ET
|
Actinium Pharmaceuticals
Webinar to be held at 9:00 AM ET to highlight Actimab-A Phase 2 clinical trial and protocol revisions agreed to by the FDAProtocol revisions agreed to by the FDA include the use of peripheral blast...
Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant
September 26, 2016 07:00 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial
September 21, 2016 08:00 ET
|
Actinium Pharmaceuticals
- Webinar to be Held on Tuesday, September 27, 2016 at 9:00 AM ET - Webinar to feature Principle Investigator Joseph Jurcic, M.D., Professor of Clinical Medicine and Director of the Hematologic...
Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial
September 20, 2016 07:00 ET
|
Actinium Pharmaceuticals
NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference
September 19, 2016 07:00 ET
|
Actinium Pharmaceuticals
- Actinium to Present on Tuesday, September 27, 2016 at 1:00 PM ET - Management Will be Available for 1-on-1 Meetings with Conference Attendees NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) --...
Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference
September 13, 2016 07:00 ET
|
Actinium Pharmaceuticals
Company to Present on Tuesday, September 13, 2016 at 10:25 AM ET Presentation can be viewed via webcast NEW YORK, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE...
Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference
September 09, 2016 07:00 ET
|
Actinium Pharmaceuticals
Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ET Presentation can be viewed via webcast NEW YORK, Sept. 09, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals,...